Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.72 |
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2955108 | 0.96 | KMT2A (0.67) | KMT2AMEN1CYP1A2ALDH1A1CYP2D6 | |
| SCHEMBL3257808 | 0.96 | KMT2A (0.67) | KMT2AMEN1CYP1A2ALDH1A1CYP2D6 | |
| SCHEMBL4634463 | 0.96 | KMT2A (0.67) | KMT2AMEN1CYP1A2ALDH1A1CYP2D6 | |
| SCHEMBL29834154 | 0.86 | KMT2A (0.79) | KMT2AMEN1CYP1A2ALDH1A1CYP2D6 | |
| SCHEMBL2962696 | 0.86 | KMT2A (0.79) | KMT2AMEN1CYP1A2ALDH1A1CYP2D6 | |
| SCHEMBL5416769 | 0.85 | KMT2A (0.54) | KMT2AMEN1CYP1A2ALDH1A1CYP2D6 | |
| SCHEMBL5326460 | 0.84 | KMT2A (0.59) | KMT2AMEN1CYP1A2ALDH1A1CYP2D6 | |
| SCHEMBL29441770 | 0.84 | KMT2A (1.00) | KMT2AMEN1CYP1A2ALDH1A1CYP2D6 | |
| SCHEMBL113945 | 0.84 | KMT2A (1.00) | KMT2AMEN1CYP1A2ALDH1A1CYP2D6 | |
| SCHEMBL29385360 | 0.84 | KMT2A (1.00) | KMT2AMEN1CYP1A2ALDH1A1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10010274-B2 | Systems, devices and methods for in situ calibration of implantable sensors | WINKELMAN JAMES (US) | 2018-07-03 | — | — | US | disclosed |
| US-20160073940-A1 | Systems, Devices And Methods For In Situ Calibration Of Implantable Sensors | WINKELMAN JAMES (US) | 2016-03-17 | — | — | US | disclosed |
| US-20140371553-A1 | SYSTEMS, DEVICES AND METHODS FOR IN SITU CALIBRATION OF IMPLANTABLE SENSORS | Winkelman, James (US) | 2014-12-18 | — | — | US | disclosed |
| US-8475685-B2 | Particle and near-field optical waveguide | KABUSHIKI KAISHA TOSHIBA (JP) | 2013-07-02 | — | — | US | disclosed |
| WO-2013090882-A1 | SYSTEMS, DEVICES AND METHODS FOR IN SITU CALIBRATION OF IMPLANTABLE SENSORS | WINKELMAN JAMES (US) | 2013-06-20 | — | — | WO | disclosed |
| US-8224410-B2 | Dermally affixed sensor device | PHARMASENS AG (CH) | 2012-07-17 | — | — | US | disclosed |
| US-20100239219-A1 | PARTICLE AND NEAR-FIELD OPTICAL WAVEGUIDE | KABUSHIKI KAISHA TOSHIBA (JP) | 2010-09-23 | — | — | US | disclosed |
| US-7772153-B2 | Separating agent for enantiomeric isomers | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-10 | — | — | US | disclosed |
| US-7772402-B2 | Optically detectable organophosphonates | AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (AT) | 2010-08-10 | — | — | US | disclosed |
| CN-100591265-C | Skin-adhering sensor device | PAUL HADVARY | 2010-02-24 | — | — | CN | disclosed |
| US-20090258422-A1 | OPTICALLY DETECTABLE ORGANOPHOSPHONATES | AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (AT) | 2009-10-15 | — | — | US | disclosed |
| US-7601845-B2 | Optically detectable organophosphonates | AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (AT) | 2009-10-13 | — | — | US | disclosed |
| EP-1706019-B1 | DERMALLY AFFIXED SENSOR DEVICE | HADVARY PAUL (CH) | 2008-09-17 | — | — | EP | disclosed |
| US-20080027296-A1 | Dermally Affixed Sensor Device | PHARMASENS AG (CH) | 2008-01-31 | — | — | US | disclosed |
| CN-1976627-A | Skin-adhering sensor device | HADVARY PAUL (CH) | 2007-06-06 | — | — | CN | disclosed |
| EP-1706019-A1 | DERMALLLY AFFIXED SENSOR DEVICE | Hadváry, Paul (CH) | 2006-10-04 | — | — | EP | disclosed |
| US-20060189796-A1 | Separating agent for enantiomeric isomers | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-24 | — | — | US | disclosed |
| US-20060134715-A1 | Optically detectable organophosphonates | AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (AT) | 2006-06-22 | — | — | US | disclosed |
| WO-2005063115-A1 | DERMALLLY AFFIXED SENSOR DEVICE | HADVARY PAUL (CH) | 2005-07-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060189796-A1 | Separating agent for enantiomeric isomers | GNE, SI, EPHX2 | KMT2A 3806/4885MEN1 1877/4885CYP1A2 1532/4885 |
| US-20090258422-A1 | OPTICALLY DETECTABLE ORGANOPHOSPHONATES | LYPLA1, CES1, LIPE | KMT2A 4771/4885MEN1 1535/4885CYP1A2 1292/4885 |
| US-20060134715-A1 | Optically detectable organophosphonates | LYPLA1, CES1, LIPE | KMT2A 4771/4885MEN1 1535/4885CYP1A2 1292/4885 |
| US-20100239219-A1 | PARTICLE AND NEAR-FIELD OPTICAL WAVEGUIDE | F2, AHR, CRY1 | KMT2A 3351/4885MEN1 3177/4885CYP1A2 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.